We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
(+0.84%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$56.7M |
| 2 |
Apollo Global Management
APO
|
+$36.8M |
| 3 |
Boeing
BA
|
+$34.1M |
| 4 |
Workday
WDAY
|
+$31.9M |
| 5 |
DOCU
DocuSign
DOCU
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$84.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$48.4M |
| 5 |
XYZ
Block Inc
XYZ
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.97% |
| 2 | Financials | 13.53% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Healthcare | 10.06% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Comp X International
CIX
$371M
| $217K | ﹤0.01% |
8,302
+6,862
| +477% | +$200K |
|
2952
Fennec Pharmaceuticals
FENC
$402M
| $217K | ﹤0.01% |
34,299
+3,911
| +13% | +$20K |
|
|
AV
2953
DELISTED
Aviva Plc
AV
| $216K | ﹤0.01% |
18,237
+56
| +0.3% | +$663 |
|
2954
Arq
ARQ
$89.3M
| $215K | ﹤0.01% |
28,451
+957
| +3% | +$6.29K |
|
2955
Waldencast
WALD
$178M
| $215K | ﹤0.01% |
53,479
-3,244
| -6% | -$11.4K |
|
2956
Coherus Oncology
CHRS
$196M
| $214K | ﹤0.01% |
155,201
+5,692
| +4% | +$6.38K |
|
2957
Prudential
PUK
$35.2B
| $214K | ﹤0.01% |
13,431
-16
| -0.1% | -$268 |
|
|
INZY
2958
DELISTED
Inozyme Pharma
INZY
| $214K | ﹤0.01% |
77,251
+434
| +0.6% | +$1.65K |
|
2959
Enanta Pharmaceuticals
ENTA
$400M
| $213K | ﹤0.01% |
37,091
+926
| +3% | +$8.88K |
|
2960
Investar Holding Corp
ISTR
$414M
| $213K | ﹤0.01% |
9,709
+200
| +2% | +$4.38K |
|
2961
CVRx
CVRX
$63.4M
| $213K | ﹤0.01% |
16,826
-144
| -0.8% | -$1.78K |
|
2962
E.W. Scripps
SSP
$304M
| $213K | ﹤0.01% |
96,460
+2,760
| +3% | +$6.37K |
|
2963
Prelude Therapeutics
PRLD
$390M
| $213K | ﹤0.01% |
166,830
+154,826
| +1,290% | +$205K |
|
2964
BRC Inc
BRCC
$250M
| $212K | ﹤0.01% |
66,749
-6,212
| -9% | -$19.4K |
|
|
MRDN
2965
Meridian Holdings Inc
MRDN
$182M
| $211K | ﹤0.01% |
8,871
+7,063
| +391% | +$197K |
|
2966
Prime Medicine
PRME
$559M
| $210K | ﹤0.01% |
71,956
+1,909
| +3% | +$6.7K |
|
2967
Peoples Bancorp of North Carolina
PEBK
$229M
| $210K | ﹤0.01% |
6,718
-15
| -0.2% | -$429 |
|
2968
Norwood Financial Corp
NWFL
$368M
| $210K | ﹤0.01% |
7,702
+25
| +0.3% | +$728 |
|
2969
Clarus
CLAR
$143M
| $209K | ﹤0.01% |
46,391
+1,460
| +3% | +$6.55K |
|
2970
Mistras Group
MG
$512M
| $209K | ﹤0.01% |
23,020
-324
| -1% | -$3.19K |
|
|
BWAY
2971
Brainsway
BWAY
$622M
| $207K | ﹤0.01% |
43,932
+4,288
| +11% | +$20.9K |
|
2972
Suncor Energy
SU
$70.3B
| $207K | ﹤0.01% |
5,805
+2,784
| +92% | +$107K |
|
|
YALA
2973
Yalla Group
YALA
$832M
| $207K | ﹤0.01% |
50,875
+310
| +0.6% | +$1.33K |
|
2974
Evolution Petroleum
EPM
$131M
| $206K | ﹤0.01% |
39,365
-1,656
| -4% | -$9.07K |
|
2975
CS Disco
LAW
$279M
| $205K | ﹤0.01% |
41,156
+3,326
| +9% | +$19.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2024 Portfolio in Review
As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
- RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
- RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
- RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
- RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
- RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.
Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.